<< previous · tutorial index · next >>
 NIAID
uses a two-step approach to funding investigator-initiated clinical trials: a Clinical Trial Planning Grant (R34) followed by a Clinical Trial Implementation Cooperative Agreement (U01).
R34s provide funding for the preparation of 1)
materials NIAID staff need to determine a project's feasibility and
2) documentation necessary
for
implementing
the clinical
trial
in the U01.
This two-step process does not apply to applications responding to requests for applications (RFA). If
you're applying for a clinical trial through an RFA, make sure you
follow
instructions in the RFA.
If you plan to apply for an investigator-initiated clinical trial,
you'll need to consider many details in addition to the information
we highlight on this tutorial page.
For more information, go to Investigator-Initiated Clinical Trial Planning and
Implementation Grants. Also, follow NIAID
Clinical Terms of Award instructions, and visit Investigator-Initiated
Clinical Trial Planning and Implementation Grants questions and answers.
Additional Resources
<< previous · tutorial index · next >> |
